Mayo Clinic's $188 million Proton Beam Therapy Program is still in the process of ramping up, but it's already turning heads within a struggling niche in the medical industry. Since opening June 23, ...

Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could differentiate ...

GREEN BAY, Wis. (WBAY) - Across our community, you’ll find unsung heroes giving of their time, talent and treasures to make Northeast Wisconsin a great place to live. WBAY is excited to begin a new ...

If you have been tracking Beam Therapeutics (BEAM), you may have noticed a renewed wave of investor curiosity following recent reports from BMO Capital. The spotlight is on the company’s BEAM-302 DNA ...

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...